Table 1. Baseline demographic and clinical characteristics.
| Variable | No. of patients (%) |
|---|---|
| Age (median year, range) | 58 (28–75) |
|
Gender | |
| Male | 54 (73.9) |
| Female | 19 (26.0) |
|
Tumour location | |
| Upper body | 10 (13.6) |
| Middle body | 25 (34.2) |
| Lower body | 36 (49.3) |
| Diffuse type | 2 (2.7) |
|
Tumour differentiation | |
| Well/median differentiated | 4 (5.4) |
| Poorly differentiated/mucinous or signet ring cell carcinoma | 69 (94.5) |
|
Pre-chemotherapy T stage | |
| T2 | 9 (12.3) |
| T3 | 42 (57.5) |
| T4 | 22 (30.1) |
|
Pre-chemotherapy N stage | |
| N− | 22 (30.1) |
| N+ | 51 (69.9) |
|
Pre-chemotherapy TNM | |
| IB | 5 (6.8) |
| II | 49 (67.1) |
| III | 19 (26.0) |